LPA and type 2 diabetes mellitus: Our data for the first time indicated that Lp(a) was an independent predictor for recurrent CVEs in T2DM patients with prior CVEs, suggesting that Lp(a) measurement may help further risk stratification for T2DM patients after they suffered a first CVE.